NDC 63323-738-06 - Famotidine
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63323-738
- Requested NDC
- 63323-738-06
- Package NDCs from labels
- 63323-738-03, 63323-738-09, 63323-738-06, 63323-738-20
- Manufacturer
- Fresenius Kabi USA, LLC
- Effective date
- 2022-10-20
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Famotidine - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2022-10-20 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63323-738-03 | Famotidine | 4 mL in 1 VIAL, MULTI-DOSE | INJECTION, SOLUTION | 4 | 6 | |
| 63323-738-06 | Famotidine | 20 mL in 1 VIAL, MULTI-DOSE | INJECTION, SOLUTION | 20 | 6 | |
| 63323-738-09 | Famotidine | 10 in 1 TRAY | INJECTION, SOLUTION | 10 | 6 | |
| 63323-738-20 | Famotidine | 10 in 1 TRAY | INJECTION, SOLUTION | 10 | 6 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63323-738-04 | ML - Milliliter | 63323-738 | c72698f4-3e89-481a-9915-d97fcc1d0c26 | 1 | 2012-07-24 |
| 63323-738-06 | ML - Milliliter | 63323-738 | ebc9ffe6-5e6d-4cca-8741-aedc76446559 | 1 | 2021-11-09 |
| 63323-738-09 | ML - Milliliter | 63323-738 | 7490ccad-99a7-45f4-8296-23639022d1a5 | 1 | 2013-02-13 |
| 63323-738-20 | ML - Milliliter | 63323-738 | f81fc1c0-2897-4dc8-a28b-ce54469f36da | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| FAMOTIDINE | ACTIVE INGREDIENT | 5QZO15J2Z8 | FAMOTIDINE INJECTION, SOLUTION [APP PHARMACEUTICALS, LLC] | 1 | |
| FAMOTIDINE | ACTIVE MOIETY | 5QZO15J2Z8 | FAMOTIDINE INJECTION, SOLUTION [APP PHARMACEUTICALS, LLC] | 1 | |
| ASPARTIC ACID | INACTIVE INGREDIENT | 30KYC7MIAI | FAMOTIDINE INJECTION, SOLUTION [APP PHARMACEUTICALS, LLC] | 1 | |
| BENZYL ALCOHOL | INACTIVE INGREDIENT | LKG8494WBH | FAMOTIDINE INJECTION, SOLUTION [APP PHARMACEUTICALS, LLC] | 1 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | FAMOTIDINE INJECTION, SOLUTION [APP PHARMACEUTICALS, LLC] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Famotidine | FAMOTIDINE | PD-Rx Pharmaceuticals, Inc. | 5798d282-ce83-49aa-bc33-13203f2b5285 | 2026-11-09 | Warnings, Adverse reactions | 5QZO15J2Z8 |
| Acid Reducer | ACID REDUCER | Demoulas Super Markets, Inc. | 63b6012e-0221-48ab-a142-2d302ed6476a | 2026-11-05 | Warnings | 5QZO15J2Z8 |
| Famotidine | FAMOTIDINE | PD-Rx Pharmaceuticals, Inc. | 2f5ec69d-926c-47a2-be47-8fef2e0ff207 | 2026-11-03 | Warnings, Adverse reactions | 5QZO15J2Z8 |
| Famotidine | FAMOTIDINE | NuCare Pharmaceutical, Inc. | 505d3c4c-5567-72cc-e054-00144ff88e88 | 2026-11-03 | Adverse reactions | 5QZO15J2Z8 |
| Mannitol | MANNITOL | Henry Schein, Inc. | e2444db1-9dfe-451f-a33c-9b00786464d2 | 2026-11-02 | Warnings, Adverse reactions | 3OWL53L36A |
| Ibuprofen and famotidine | IBUPROFEN AND FAMOTIDINE | REMEDYREPACK INC. | b969bb72-66de-47ce-9d77-64d029e1a5c9 | 2026-10-29 | Boxed warning, Warnings, Adverse reactions | 5QZO15J2Z8 |
| ENCON EYEWASH | EYEWASH | Encon Safety Products, Inc. | 485c691e-f6a8-4836-e063-6294a90a16fc | 2026-10-29 | Warnings | 059QF0KO0R |
| FAMOTIDINE | FAMOTIDINE | PD-Rx Pharmaceuticals, Inc. | a3b50576-cd40-4f7e-9506-bd0a61988424 | 2026-10-29 | Warnings, Adverse reactions | 5QZO15J2Z8 |
| Famotidine | FAMOTIDINE | PD-Rx Pharmaceuticals, Inc. | 002875d2-8c30-2d2e-e063-6294a90ae01e | 2026-10-28 | Warnings, Adverse reactions | 5QZO15J2Z8 |
| Ibuprofen and famotidine | IBUPROFEN AND FAMOTIDINE | Bryant Ranch Prepack | ee69d3cb-dc95-410c-a7c8-6623073a923d | 2026-10-26 | Boxed warning, Warnings, Adverse reactions | 5QZO15J2Z8 |
| Bacteriostatic Water | WATER | Henry Schein, Inc. | a833502e-a622-4e81-8c58-cef6ccb6c4c9 | 2026-10-26 | Boxed warning, Warnings, Adverse reactions | 059QF0KO0R |
| BACTERIOSTATIC | WATER | Elementco, S.A.P.I. de C.V. | 5e7465d8-dbe4-2f86-e063-6394a90a8dfb | 2026-10-23 | Warnings | LKG8494WBH |
| Ibuprofen and famotidine | IBUPROFEN AND FAMOTIDINE | Ascend Laboratories, LLC | 4493d4cd-ca8e-4b0a-9b65-b75e55bf8b9e | 2026-10-23 | Boxed warning, Warnings, Adverse reactions | 5QZO15J2Z8 |
| Fendall 1000 Pure Flow | PURIFIED WATER | Protective Industrial Products, Inc. | 55a2f4da-bb1e-8ead-e063-6394a90af72e | 2026-10-21 | Warnings | 059QF0KO0R |
| Walgreens Sterile Soothing Eye Wash | PURIFIED WATER | Walgreens | a62e3294-abd6-48dc-81b1-62a809bdc968 | 2026-10-19 | Warnings | 059QF0KO0R |
| Famotidine | FAMOTIDINE | Redpharm Drug | 55730918-d9e8-eaad-e063-6394a90aeda2 | 2026-10-15 | Warnings, Adverse reactions | 5QZO15J2Z8 |
| COMPLETE ACID REDUCER | FAMOTIDINE, CALCIUM CARBONATE, MAGNESIUM HYDROXIDE | CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED | b023cd92-eabb-474b-9b5a-4b46cf48256b | 2026-10-09 | Warnings | 5QZO15J2Z8 |
| Rolaids ACID DEFENSE | FAMOTITINE | The Procter & Gamble Manufacturing Company | 3bdbeabb-6b06-5468-e063-6394a90a03c9 | 2026-10-02 | Warnings | 5QZO15J2Z8 |
| ACID REDUCER | FAMOTIDINE | CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED | 7e5f9492-1d58-47a3-aac6-c41c81b348d5 | 2026-10-02 | Warnings | 5QZO15J2Z8 |
| ACID REDUCER | FAMOTIDINE | Amazon.com Services LLC | baab51e5-968a-490e-8f3c-f507adcdd64d | 2026-09-30 | Warnings | 5QZO15J2Z8 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.